Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience

Ovarian cancer is the most lethal gynecological cancer, and despite years of research, with the exception of a BRCA mutation driving the use of PARP inhibitors, no new prognostic/predictive biomarkers are clinically available. Improvement in biomarker selection and validation may derive from the sys...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cells
Asıl Yazarlar: Califano, Daniela, Russo, Daniela, Scognamiglio, Giosuè, Losito, Nunzia Simona, Spina, Anna, Bello, Anna Maria, Capiluongo, Anna, Galdiero, Francesca, De Cecio, Rossella, Bevilacqua, Simona, Gargiulo, Piera, Marchesi, Edoardo, Canevari, Silvana, Perrone, Francesco, Daniele, Gennaro, De Cecco, Loris, Mezzanzanica, Delia, Pignata, Sandro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226822/
https://ncbi.nlm.nih.gov/pubmed/32272732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9040903
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller